Who owns Passage Bio Inc?
- Ticker: PASG
- CUSIP Number: 702712100
Tip: Access positions for across all investors
Analyze quarterly positions in Passage Bio with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Passage Bio stock
Who bought or sold Passage Bio Inc this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| OrbiMed Advisors | 10M | $14M | 0% | Mar 2024 |
|
| Versant Venture Management | 5.0M | $6.7M | 0% | Mar 2024 |
|
| Lynx1 Capital Management | 4.8M | $6.5M | 1178% | Mar 2024 |
|
| Vanguard Group | 2.1M | $2.8M | 3% | Mar 2024 |
|
| Tang Capital Management | 1.5M | $2.0M | -38% | Mar 2024 |
|
| Acadian Asset Management | 961k | $1.3M | 59% | Mar 2024 |
|
| BlackRock | 923k | $1.2M | -9% | Mar 2024 |
|
| Millennium Management | 866k | $1.2M | 10% | Mar 2024 |
|
| Bridgeway Capital Management | 556k | $751k | 10% | Mar 2024 |
|
| Acuitas Investments | 469k | $634k | 12% | Mar 2024 |
|
| Geode Capital Management | 384k | $519k | 16% | Mar 2024 |
|
| Citadel Advisors | 242k | $327k | -23% | Mar 2024 |
|
| Two Sigma Advisers | 210k | $283k | 0% | Mar 2024 |
|
| Two Sigma Investments | 201k | $272k | 0% | Mar 2024 |
|
| Rbf Capital | 143k | $193k | 0% | Mar 2024 |
|
| Fiduciary Trust Company | 115k | $116k | 0% | Dec 2023 |
|
| Marquette Asset Management | 86k | $115k | 0% | Mar 2024 |
|
| Northern Trust | 84k | $114k | 59% | Mar 2024 |
|
| DLK Investment Management | 64k | $86k | 0% | Mar 2024 |
|
| XTX Topco | 43k | $58k | 101% | Mar 2024 |
|
| Goldman Sachs Group | 27k | $36k | 0% | Mar 2024 |
|
| Virtu Financial | 25k | $34k | -62% | Mar 2024 |
|
| Marshall Wace | 22k | $30k | 100% | Mar 2024 |
|
| HighTower Advisors | 22k | $29k | -2% | Mar 2024 |
|
| FMR | 21k | $28k | -66% | Mar 2024 |
|
| Morgan Stanley | 14k | $14k | -92% | Mar 2024 |
|
| Barclays | 13k | $18k | 0% | Mar 2024 |
|
| Cubist Systematic Strategies | 11k | $15k | 100% | Mar 2024 |
|
| Citigroup | 4.0k | $5.4k | -17% | Mar 2024 |
|
| Rhumbline Advisers | 783.00 | $1.1k | 0% | Mar 2024 |
|
| Royal Bank of Canada | 500.00 | $1.0k | 32% | Mar 2024 |
|
| Wells Fargo & Company | 309.00 | $416.995500 | 2% | Mar 2024 |
|
| Jpmorgan Chase & Co | 273.00 | $368.986800 | -80% | Mar 2024 |
|
| LRI Investments | 225.00 | $303.997500 | 100% | Mar 2024 |
|
| Advisor Group Holdings | 217.00 | $292.993400 | 0% | Mar 2024 |
|
| TSFG | 100.00 | $0 | 0% | Mar 2024 |
|
| Group One Trading | 47.00 | $62.998800 | 0% | Mar 2024 |
|
| Tower Research Capital | 34.00 | $45.998600 | -100% | Mar 2024 |
|
| Federation des caisses Desjardins du Quebec | 10.00 | $14.000000 | 100% | Mar 2024 |
|
| CWM | 5.00 | $0 | 0% | Mar 2024 |
|
| Qube Research & Technologies | 4.00 | $5.000000 | 0% | Mar 2024 |
|
| Bank of America Corporation | 1.00 | $1.000000 | -97% | Mar 2024 |
|
Who sold out of Passage Bio?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Weiss Multi-strategy Advisers | Dec 2023 | 243k | $245k |
| Two Sigma Securities | Dec 2023 | 40k | $41k |
| Bank of New York Mellon | Dec 2023 | 14k | $14k |
| Simplex Trading | Dec 2023 | 2.1k | $2.0k |
| UBS Group | Dec 2023 | 1.1k | $1.1k |
| Steward Partners Investment Advisory | Dec 2023 | 1.0k | $1.0k |
| Federated Investors | Sep 2023 | 511.00 | $335.982500 |